Bionano Genomics (BNGO) Operating Margin (2017 - 2025)
Historic Operating Margin for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to 115.9%.
- Bionano Genomics' Operating Margin rose 6069900.0% to 115.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 127.94%, marking a year-over-year increase of 2230400.0%. This contributed to the annual value of 337.87% for FY2024, which is 2581100.0% up from last year.
- As of Q3 2025, Bionano Genomics' Operating Margin stood at 115.9%, which was up 6069900.0% from 115.85% recorded in Q2 2025.
- In the past 5 years, Bionano Genomics' Operating Margin registered a high of 115.85% during Q2 2025, and its lowest value of 1214.98% during Q3 2023.
- In the last 5 years, Bionano Genomics' Operating Margin had a median value of 444.21% in 2021 and averaged 410.86%.
- Per our database at Business Quant, Bionano Genomics' Operating Margin tumbled by -7697700bps in 2023 and then skyrocketed by 6069900bps in 2025.
- Quarter analysis of 5 years shows Bionano Genomics' Operating Margin stood at 456.73% in 2021, then fell by 0bps to 456.81% in 2022, then surged by 49bps to 232.75% in 2023, then surged by 37bps to 146.28% in 2024, then rose by 21bps to 115.9% in 2025.
- Its Operating Margin was 115.9% in Q3 2025, compared to 115.85% in Q2 2025 and 131.1% in Q1 2025.